Mycologix is focused on the development of low cost, highly efficient biological pre-treatment process for 2nd generation biofuels. The company was formed in 2009 based on more than 20 years of research by Dr. Richard Murphy of the Deptartment of Biological Sciences at Imperial College London. Mycologix has secured grant support from TSB and the Carbon Trust Incubator programme. Mycologix is being developed by Nick Brooks, previously an Entrepreneur-in-Residence. Nick spent 30 years at Shell in a variety of senior management positions. Since leaving Shell in 2005, Nick has been CEO of several Biofuels businesses, including Sun Biofuelds, Bioverda Europe, and BioEnergy Africa.

